There’s been encouraging news about the Oxford Covid-19 vaccine this week from a trial involving about 1,000 people. But how great is the challenge in scaling up from making a few thousand doses of the vaccine to manufacturing two billion by the end of this year? Sandy Douglas of Oxford’s Jenner Institute explains how they plan to mass-produce the vaccine safely given the speed and magnitude of the scale up. A new kind of treatment for Covid-19 may come from an unlikely source: llamas and alpacas, the South American relatives of the camel. Camelids produce unusually small and simple antibodies …
science & medicine,
advances in science,
New research on how long our defences against the coronavirus last.
African scientists have developed a reliable, quicker and cheaper mass testing method
Why a minority become gravely ill is still a mystery
Siberia has seen 38 degrees Celsius, 100 degrees Fahrenheit
A readily available drug prevents some deaths, and others may also be useful
Efforts to eradicate locust swarms and save harvests continue despite the pandemic
Understanding viral damage to the brain and heart
The number of cases and deaths may be much higher than official figures show
More than a hundred vaccines are in development to fight the virus
Understanding which situations pose the highest risk for virus transmission is key.
Research from New York shows how our own immune response is responding to Covid 19
Early trials suggest Remdesivir can aid recovery
Tentative steps to relax the lockdown
The impossibility of social distancing and even handwashing in crowded refugee camps
As cases spread in Nigeria, can lessons from Ebola counter covid 19?
Why staying home is the best defence against Covid -19
Research from Italy and China, shows many people have the coronavirus but no symptoms
The pattern of transmission and prospects for drug treatments.